177Lu-3BP-227
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-3BP-227, covering 2023-12-12 to 2023-12-12. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. [Phase 1]